LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $33.9B | +85.4% | 36.3% | 6.2% |
| Shareholders' equity (Q2 2026) | $33.9B |
|---|---|
| YoY | +85.4% |
| 5-year CAGR | 36.3% |
| 10-year CAGR | 6.2% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $26.5B | +85.9% |
| 2024 | $14.3B | +32.5% |
| 2023 | $10.8B | +1.1% |
| 2022 | $10.6B | +18.6% |
| 2021 | $9.0B | +59.2% |
| 2020 | $5.6B | +116.4% |
| 2019 | $2.6B | −73.5% |
| 2018 | $9.8B | −15.2% |
| 2017 | $11.6B | −17.2% |
| 2016 | $14.0B | −3.9% |
| 2015 | $14.6B | −5.2% |
| 2014 | $15.4B | −12.8% |
| 2013 | $17.6B | +19.4% |
| 2012 | $14.8B | +9.0% |
| 2011 | $13.5B | +9.0% |
| 2010 | $12.4B | +30.4% |
| 2009 | $9.5B | +41.4% |
| 2008 | $6.7B | — |